AbouttheCover
摘要: Advancedhepatocellularcarcinoma(HCC)isdifficulttotreatSorafenibisaselectiveinhibitorofvascularendothelialgrowthfactorreceptor2(VEGFR2).HCCsarehypervasculartumors.However,thedurabilityofresponsetosorafenibislimited.Thecoverartshowsanewexplanationforwhytheanti-tumoreffectsofsorafenibonHCCmaybeshort-livedandwhyalternateanti-VEGF ...
(共1頁)
開通會(huì)員,享受整站包年服務(wù)